China's BMP Sunstone Reports Higher Profits With Launch Of National Healthcare Reforms
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - U.S.-listed Chinese pharmaceutical manufacturer and distributor BMP Sunstone reported record profits in 2010
You may also be interested in...
BMP Sunstone Sees Larger Market Share From China Healthcare Reforms, PE Buy Out In The Works?
SHANGHAI - U.S.-listed Chinese pharmaceutical manufacturer and distributor BMP Sunstone reported a 25.8 percent increase in revenue in the second quarter compared to the same year-ago period, for $40.9 million in revenue. The company anticipates gaining market share from China's ongoing healthcare reforms, for which the Chinese government has pledged to invest $124 billion from 2009 to 2011
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).